Lin Kai-Yang, Zheng Wei-Ping, Bei Wei-Jie, Chen Shi-Qun, Islam Sheikh Mohammed Shariful, Liu Yong, Xue Lin, Tan Ning, Chen Ji-Yan
Southern Medical University, Guangzhou 510515, China; Department of Cardiology, Provincial Key Laboratory of Coronary Heart Disease, Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510100, China; Department of Geriatric Medicine, Fujian Provincial Hospital, Fujian Provincial Institute of Clinical Geriatrics, Fujian Provincial Key Laboratory of Geriatric Disease, Fujian Medical University, Fuzhou 350001, China.
Department of Geriatric Medicine, Fujian Provincial Hospital, Fujian Provincial Institute of Clinical Geriatrics, Fujian Provincial Key Laboratory of Geriatric Disease, Fujian Medical University, Fuzhou 350001, China.
Int J Cardiol. 2017 Mar 1;230:402-412. doi: 10.1016/j.ijcard.2016.12.095. Epub 2016 Dec 26.
A few studies developed simple risk model for predicting CIN with poor prognosis after emergent PCI. The study aimed to develop and validate a novel tool for predicting the risk of contrast-induced nephropathy (CIN) in patients undergoing emergent percutaneous coronary intervention (PCI).
692 consecutive patients undergoing emergent PCI between January 2010 and December 2013 were randomly (2:1) assigned to a development dataset (n=461) and a validation dataset (n=231). Multivariate logistic regression was applied to identify independent predictors of CIN, and established CIN predicting model, whose prognostic accuracy was assessed using the c-statistic for discrimination and the Hosmere Lemeshow test for calibration.
The overall incidence of CIN was 55(7.9%). A total of 11 variables were analyzed, including age >75years old, baseline serum creatinine (SCr)>1.5mg/dl, hypotension and the use of intra-aortic balloon pump(IABP), which were identified to enter risk score model (Chen). The incidence of CIN was 32(6.9%) in the development dataset (in low risk (score=0), 1.0%, moderate risk (score:1-2), 13.4%, high risk (score≥3), 90.0%). Compared to the classical Mehran's and ACEF CIN risk score models, the risk score (Chen) across the subgroup of the study population exhibited similar discrimination and predictive ability on CIN (c-statistic:0.828, 0.776, 0.853, respectively), in-hospital mortality, 2, 3-years mortality (c-statistic:0.738.0.750, 0.845, respectively) in the validation population.
Our data showed that this simple risk model exhibited good discrimination and predictive ability on CIN, similar to Mehran's and ACEF score, and even on long-term mortality after emergent PCI.
一些研究开发了简单的风险模型来预测急诊经皮冠状动脉介入治疗(PCI)后预后不良的对比剂肾病(CIN)。本研究旨在开发并验证一种用于预测接受急诊经皮冠状动脉介入治疗(PCI)患者发生对比剂肾病(CIN)风险的新工具。
将2010年1月至2013年12月期间连续接受急诊PCI的692例患者随机(2:1)分配至一个开发数据集(n = 461)和一个验证数据集(n = 231)。应用多因素逻辑回归来识别CIN的独立预测因素,并建立CIN预测模型,使用c统计量进行鉴别评估其预后准确性,并使用Hosmere Lemeshow检验进行校准评估。
CIN的总体发生率为55例(7.9%)。共分析了11个变量,包括年龄>75岁、基线血清肌酐(SCr)>1.5mg/dl、低血压以及使用主动脉内球囊反搏(IABP),这些变量被确定纳入风险评分模型(Chen)。在开发数据集中CIN的发生率为32例(6.9%)(低风险(评分=0),1.0%;中度风险(评分:1 - 2),13.4%;高风险(评分≥3),90.0%)。与经典的Mehran和ACEF CIN风险评分模型相比,研究人群亚组中的风险评分(Chen)在CIN(c统计量分别为:0.828、0.776、0.853)、住院死亡率、2年和3年死亡率(验证人群中c统计量分别为:0.738、0.750、0.845)方面表现出相似的鉴别和预测能力。
我们的数据表明,这个简单的风险模型在CIN方面表现出良好的鉴别和预测能力,与Mehran评分和ACEF评分相似,甚至在急诊PCI后的长期死亡率方面也是如此。